Ignite Creation Date:
2024-06-16 @ 11:52 AM
Last Modification Date:
2024-10-26 @ 3:32 PM
Study NCT ID:
NCT06459310
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-06-14
First Post:
2024-06-03
Brief Title:
Pilot Study on Evaluating the Geroprotective Effect of Metformin
Sponsor:
Xuanwu Hospital Beijing
Organization:
Xuanwu Hospital Beijing
Study Overview
Official Title:
A Phase II Exploratory Clinical Study Investigating the Geroprotective Effect of Metformin in Middle-aged and Elderly People
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
AGE-M
Brief Summary:
The objective of this research is to assess the efficacy of oral metformin in mitigating the aging process in middle-aged and elderly males to pinpoint sensitive indicators of human senescence and to offer innovative frameworks and scientific insights for pharmaceutical interventions in aging
Detailed Description:
Subjects in both the metformin hydrochloride extended-release tablets treatment group and the placebo group received two tablets 500 mg each once daily after dinner continuing for a one-year period of drug intervention
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
False
Is an FDA AA801 Violation?:
None